Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xtant Medical Holdings (XTNT) Interest Expenses (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Interest Expenses for 16 consecutive years, with $904000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Interest Expenses fell 24.6% to $904000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $4.1 million, a 6.32% increase, with the full-year FY2024 number at $4.2 million, up 41.59% from a year prior.
  • Interest Expenses was $904000.0 for Q3 2025 at Xtant Medical Holdings, down from $1.0 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $1.2 million in Q3 2024 to a low of $1000.0 in Q1 2021.
  • A 5-year average of $670421.1 and a median of $760000.0 in 2023 define the central range for Interest Expenses.
  • Peak YoY movement for Interest Expenses: tumbled 99.91% in 2021, then skyrocketed 35800.0% in 2022.
  • Xtant Medical Holdings' Interest Expenses stood at $466000.0 in 2021, then rose by 6.22% to $495000.0 in 2022, then skyrocketed by 65.25% to $818000.0 in 2023, then surged by 38.63% to $1.1 million in 2024, then dropped by 20.28% to $904000.0 in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Interest Expenses are $904000.0 (Q3 2025), $1.0 million (Q2 2025), and $1.0 million (Q1 2025).